Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sho Aoki

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Biological Cybernetics|February 23, 2013
Contributions of phase resetting and interlimb coordination to the adaptive control of hindlimb obstacle avoidance during locomotion in rats: a simulation studyShinya Aoi, Takahiro Kondo, Naohiro Hayashi, et al.
Oncotarget|August 21, 2018
STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic targetErika Onozawa, Haruna Shibayama, Honami Takada, et al.
Oncology Letters|June 22, 2018
Potent antitumor effect of combination therapy with sub-optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myelomaShiori Kinoshita, Masaki Ri, Takashi Kanamori, et al.
Brain & Development|September 26, 2021
Abnormal cortical responses elicited by audiovisual movies in patients with autism spectrum disorder with atypical sensory behavior: A magnetoencephalographic studyJunko Matsuzaki, Kuriko Kagitani-Shimono, Sho Aoki, et al.
Cancer Medicine|July 20, 2024
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasoneTakuto Tachita, Masaki Ri, Sho Aoki, et al.
Cancer Science|February 16, 2020
Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myelomaTakuto Tachita, Shiori Kinoshita, Masaki Ri, et al.
Oncotarget|March 9, 2018
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunitsTakashi Yoshida, Masaki Ri, Takashi Kanamori, et al.
International Journal of Hematology|May 23, 2019
Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myelomaReham Ashour, Masaki Ri, Sanaa Shaker Aly, et al.
Cerebellum (London, England)|June 8, 2018
Cerebellar Modules and Their Role as Operational Cerebellar Processing Units: A Consensus paper [corrected]Richard Apps, Richard Hawkes, Sho Aoki, et al.
Cerebellum (London, England)|June 23, 2018
Correction to: Cerebellar Modules and Their Role as Operational Cerebellar Processing Units: A Consensus paperRichard Apps, Richard Hawkes, Sho Aoki, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Biological Cybernetics|February 23, 2013
Contributions of phase resetting and interlimb coordination to the adaptive control of hindlimb obstacle avoidance during locomotion in rats: a simulation studyShinya Aoi, Takahiro Kondo, Naohiro Hayashi, et al.
Oncotarget|August 21, 2018
STAT3 is constitutively activated in chronic active Epstein-Barr virus infection and can be a therapeutic targetErika Onozawa, Haruna Shibayama, Honami Takada, et al.
Oncology Letters|June 22, 2018
Potent antitumor effect of combination therapy with sub-optimal doses of Akt inhibitors and pomalidomide plus dexamethasone in multiple myelomaShiori Kinoshita, Masaki Ri, Takashi Kanamori, et al.
Brain & Development|September 26, 2021
Abnormal cortical responses elicited by audiovisual movies in patients with autism spectrum disorder with atypical sensory behavior: A magnetoencephalographic studyJunko Matsuzaki, Kuriko Kagitani-Shimono, Sho Aoki, et al.
Cancer Medicine|July 20, 2024
Comprehensive analysis of serum cytokines in patients with multiple myeloma before and after lenalidomide and dexamethasoneTakuto Tachita, Masaki Ri, Sho Aoki, et al.
Cancer Science|February 16, 2020
Expression, mutation, and methylation of cereblon-pathway genes at pre- and post-lenalidomide treatment in multiple myelomaTakuto Tachita, Shiori Kinoshita, Masaki Ri, et al.
Oncotarget|March 9, 2018
Potent anti-tumor activity of a syringolin analog in multiple myeloma: a dual inhibitor of proteasome activity targeting β2 and β5 subunitsTakashi Yoshida, Masaki Ri, Takashi Kanamori, et al.
International Journal of Hematology|May 23, 2019
Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myelomaReham Ashour, Masaki Ri, Sanaa Shaker Aly, et al.
Cerebellum (London, England)|June 8, 2018
Cerebellar Modules and Their Role as Operational Cerebellar Processing Units: A Consensus paper [corrected]Richard Apps, Richard Hawkes, Sho Aoki, et al.
Cerebellum (London, England)|June 23, 2018
Correction to: Cerebellar Modules and Their Role as Operational Cerebellar Processing Units: A Consensus paperRichard Apps, Richard Hawkes, Sho Aoki, et al.
Pageof 3